Long-term Follow-up of Patients with Coronary Artery Disease Undergoing Medical Treatment: A Sex-Specific Analysis

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background While sex-based differences in coronary artery disease (CAD) are well-recognized, data on long-term outcomes for patients managed with medical therapy alone, without revascularization, remain limited. This study aimed to investigate sex-specific differences in risk profiles, long-term mortality, and major adverse cardiovascular events (MACE) in a large cohort of patients with angiographically confirmed CAD undergoing medical treatment. Methods This retrospective cohort study included 2,050 patients (697 women, 1,353 men) with angiographically confirmed CAD (≥ 50% stenosis in at least one major vessel) who were managed medically at the Tehran Heart Center. Baseline demographic, clinical, and angiographic data were collected. Patients were followed for a median of 10.6 years to assess the primary outcomes of all-cause mortality and MACE (a composite of myocardial infarction, stroke, coronary revascularization, or death). Sex-stratified Cox proportional hazards models were used to identify independent predictors for each outcome. Results At baseline, women were older and had a significantly higher prevalence of diabetes, hypertension, and hyperlipidemia. Conversely, men had markedly higher rates of smoking and opium use. Over the follow-up period, Kaplan-Meier analysis showed that men had a higher cumulative hazard of mortality, whereas women had a higher cumulative hazard of MACE. In multivariable analysis, significant predictors of mortality in both sexes included advanced age, three-vessel disease, diabetes, and renal failure. Sex-specific predictors of mortality included peripheral vascular disease (stronger risk in women), a protective effect of family history of CAD (in women), and COPD and opium use (in men). For MACE, multi-vessel disease was a significant predictor in both sexes, while hypertension and prior cerebrovascular accident were independent predictors only in men. Conclusions In patients with established CAD managed medically, there are significant sex-specific differences in baseline risk profiles and long-term outcomes. Men face a higher risk of all-cause mortality, while women experience a greater burden of non-fatal cardiovascular events. These findings underscore the necessity of incorporating sex-aware strategies into the risk stratification and long-term management of coronary artery disease.

Article activity feed